Literature DB >> 19967512

The T-dependent antibody response to keyhole limpet hemocyanin in rodents.

Lisa M Plitnick, Danuta J Herzyk.   

Abstract

Central to the evaluation of potential immunotoxicants is the concept that measurement of multiple parameters is required for the determination of toxicity toward the immune system. A carefully considered integration of endpoints involved in the immune response should be used to determine an immunotoxic effect. A functional evaluation, specifically the rodent T-cell-dependent antibody response (TDAR) model developed for regulated immunotoxicity evaluations, has been established to detect potential immunotoxicity, especially immunosuppression, caused by chemicals and novel pharmaceuticals in development. This chapter provides an overview and detailed procedures involved in the TDAR assay that measures the immune response (i.e., antibody production) to an introduced antigen (i.e., keyhole limpet hemocyanin (KLH)) in rats or mice treated with a chemical (e.g., a known immunotoxicant and/or a new drug candidate). The TDAR model of competent immune function requires the participation of multiple effector cells such as antigen presenting cells, T lymphocytes, and B lymphocytes to produce the final product, the antigen-specific antibody response. Thus, alterations in the level of antibody production to the specific antigen may reflect effects on any or all of the cell populations involved in TDAR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19967512     DOI: 10.1007/978-1-60761-401-2_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies.

Authors:  Ashwin Swaminathan; Robyn M Lucas; Keith Dear; Anthony J McMichael
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

2.  Immune responses to human factor IX in haemophilia B mice of different genetic backgrounds are distinct and modified by TLR4.

Authors:  B K Sack; X Wang; A Sherman; G L Rogers; D M Markusic
Journal:  Haemophilia       Date:  2014-11-23       Impact factor: 4.287

3.  Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats.

Authors:  Rob J Vandebriel; Elisa Cm Tonk; Liset J de la Fonteyne-Blankestijn; Eric R Gremmer; Henny W Verharen; Leo T van der Ven; Henk van Loveren; Wim H de Jong
Journal:  Part Fibre Toxicol       Date:  2014-05-07       Impact factor: 9.400

4.  Immunotoxicological Evaluation of Genetically Modified Rice Expressing Cry1Ab/Ac Protein (TT51-1) by a 6-Month Feeding Study on Cynomolgus Monkeys.

Authors:  Xiaoyan Tan; Xiaobing Zhou; Yao Tang; Jianjun Lv; Lin Zhang; Li Sun; Yanwei Yang; Yufa Miao; Hua Jiang; Gaofeng Chen; Zhiying Huang; Xue Wang
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

5.  Safety immunopharmacology: evaluation of the adverse potential of pharmaceuticals on the immune system.

Authors:  Jacques Descotes
Journal:  J Pharmacol Toxicol Methods       Date:  2012-05-14       Impact factor: 1.950

Review 6.  Challenges and approaches for the development of safer immunomodulatory biologics.

Authors:  Jean G Sathish; Swaminathan Sethu; Marie-Christine Bielsky; Lolke de Haan; Neil S French; Karthik Govindappa; James Green; Christopher E M Griffiths; Stephen Holgate; David Jones; Ian Kimber; Jonathan Moggs; Dean J Naisbitt; Munir Pirmohamed; Gabriele Reichmann; Jennifer Sims; Meena Subramanyam; Marque D Todd; Jan Willem Van Der Laan; Richard J Weaver; B Kevin Park
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 112.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.